We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Bacterial Toxin Sets the Course for Infection

By LabMedica International staff writers
Posted on 21 Nov 2013
Various toxins and effector proteins of bacterial pathogens have been found to manipulate eukaryotic cell machineries to promote persistence and proliferation within their hosts.

Some isolates of Yersinia pseudotuberculosis produce the cytotoxic necrotizing factor (CNFγ), but the functional consequences of this toxin for host-pathogen interactions during the infection are unknown.

Scientists at Helmholtz Center for Infection Research (Brunswick, Germany) cultured Yersinia strains in Luria-Bertani (LB) broth at 25 °C or 37 °C. More...
All DNA manipulations, polymerase chain reactions, restriction digestions, ligations, and transformations were performed using standard techniques. The β-galactosidase activity was determined for three independent cultures of bacteria.

Activation of Ras homolog gene family, member A (RhoA) was tested using the Rho activation assay kit (Millipore; Billerica, MA, USA) and activation of ras-related C3 botulinum toxin substrate 1 (Rac1) and cell division control protein 42 homolog (Cdc42) was determined with the Rho/Rac/Cdc42 Activation Assay Combo Kit (Cell Biolabs; San Diego, CA, USA).

In order to elucidate its function, the scientists genetically modified a bacterial strain that usually forms CNFγ in such a way that it lost the ability to produce this factor. They identified the molecular target that CNFγ manipulates, generating the dramatic consequences that involve the so-called small Rho guanosine triphosphate enzymes (GTPases). These enzymes initiate a whole cascade of events, for example alteration of the cytoskeleton. This leads to pores in the host cell surface, through which bacterial syringes can more efficiently transport active agents into the cell. The observed cell mortality of the immune cells is introduced through Rho GTPases as well.

Petra Dersch, PhD, a professor and senior author of the study explained, “We have discovered a very clever strategy of Yersinia pseudotuberculosis. With the aid of CNFγ, the bacterium manipulates the host cell in such a manner that the injection apparatus can work more effectively. It sets the course for an efficient infection and triggers onset of the disease.” The authors concluded that CNFγ is important for pathogenicity by showing that this toxin modulates inflammatory responses, protects the bacteria from attacks of innate immune effectors and enhances the severity of a Yersinia infection. The study was published on November 7, 2013, in the journal Public Library of Science Pathogens.

Related Links:

Helmholtz Centre for Infection Research
Millipore 
Cell Biolabs 



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.